Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2020

Oct 27, 2020

BUY
$8.49 - $19.54 $1,698 - $3,908
200 Added 5.41%
3,900 $0
Q2 2020

Jul 22, 2020

SELL
$7.44 - $11.29 $37,200 - $56,449
-5,000 Reduced 57.47%
3,700 $5,000
Q1 2020

May 07, 2020

BUY
$6.94 - $14.22 $28,454 - $58,302
4,100 Added 89.13%
8,700 $9,000
Q4 2019

Feb 06, 2020

BUY
$7.99 - $37.6 $34,357 - $161,680
4,300 Added 1433.33%
4,600 $1,000
Q3 2019

Oct 28, 2019

BUY
$19.17 - $27.4 $3,834 - $5,480
200 Added 200.0%
300 $0
Q2 2019

Aug 09, 2019

SELL
$22.93 - $42.84 $91,720 - $171,360
-4,000 Reduced 97.56%
100 $0
Q1 2019

May 10, 2019

BUY
$32.69 - $47.91 $134,029 - $196,431
4,100 New
4,100 $2,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $939M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.